Zota Health Care LImited — Important, 27-12-2024: Updates

Zota Health Care Limited has secured product registration licenses for two pharmaceutical products in Kyrgyzstan: Zotamet-1000 (Metformin Tablets BP 1000 mg) for diabetes management and CDTEL-40 (Telmisartan Tablets USP 40 mg) for hypertension treatment. These licenses are valid for five years, with the option for renewal afterward. The company plans to commence exports of these products to Kyrgyzstan in the near term, potentially enhancing its market reach and revenue streams. This expansion could provide a positive outlook for the company's growth trajectory.